1 / 7

Point of Care & Rapid Diagnostics Market1

The Global Point of Care & Rapid Diagnostics Market is expected to reach USD 72.0 billion by 2027 from an estimated USD 43.2 billion in 2022, at a CAGR of 10.8% from 2022 to 2027.

Rachel38
Download Presentation

Point of Care & Rapid Diagnostics Market1

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Point of Care & Rapid Diagnostics Market Global Forecast to 2027 Point of Care & Rapid Diagnostics Market is expected to reach USD 72.0 billion by 2027 Growing at a CAGR of 10.8% (2022 – 2027)

  2. POINT OF CARE & RAPID DIAGNOSTICS MARKET MARKET OPPORTUNITY OVER NEXT 5 YEARS NEXT 5 YEARS 43.2 bn CAGR of 2022 – 2027 CAGR BY PRODUCT KEY MARKET PLAYERS 72bn ▪ Abbott Laboratories (US) ▪ Siemens Healthineers AG (Germany) ▪ Quidel Corporation (US) ▪ F. Hoffman-La Roche Ltd. (Switzerland) ▪ Danaher Corporation (US) ▪ Becton ▪ Dickinson and Company (US) ▪Glucose ▪Infectious Disease(HIV, Hepatitis C) ▪Pregnancy Test 2022 2027 North America Europe Asia Pacific Rest of the World BY END USER ▪Pharmacy ▪Hospital ▪Home

  3. The Global Point of Care & Rapid Diagnostics Market is expected to reach USD 72.0 billion by 2027 from an estimated USD 43.2 billion in 2022, at a CAGR of 10.8% from 2022 to 2027. The growth of the global Point of Care diagnostics market can be attributed to factors such as increasing prevalence of respiratory diseases (such as COVID-19 and influenza) across the globe, and improved access to point-of-care devices through online platforms are some of the other key factors likely to drive the long-term growth of the point-of-care diagnostics market. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=106829185 Key Players: Abbott Laboratories (US), Siemens Healthineers AG (Germany), Quidel Corporation (US), F. Hoffman-La Roche Ltd. (Switzerland), Danaher Corporation (US), Becton, Dickinson and Company (US), Chembio Diagnostics (US), EKF Diagnostics (UK), Trinity Biotech plc (Ireland), Instrumentation Laboratory (a Werfen Company) (US), Nova Biomedical (US), PTS Diagnostics (US), Sekisui Diagnostics (US), Thermo Fisher Scientific (US), and bioMérieux S.A. (France)

  4. Rapid Diagnostics Market Dynamics Driver: High prevalence of infectious diseases POC tests can greatly improve the management of infectious diseases, especially in developing countries where access to timely medical care is a challenge and the healthcare infrastructure is antiquated and sparse. According to UNAIDS, around 20.6 million people were living with HIV in East and Southern Africa in 2018. In 2019, 20,000 new HIV cases were registered in the Middle East and North Africa (Source: UNAIDS Data 2020). In the Asia Pacific, an estimated 5.8 million people were suffering from HIV in 2019, led by India and China. According to UNAIDS, in 2019, approximately 2.1 million people in India were infected with HIV. The high prevalence of HIV is likely to boost the demand for point-of-care diagnostics, further accelerating the treatment of HIV infection. Opportunity: Emerging markets Emerging markets such as China, India, Brazil, and Mexico are expected to offer significant growth opportunities for players operating in the POC diagnostics market. This is primarily due to the high and growing prevalence of infectious and lifestyle diseases in these countries. Globally, China has the highest number of diabetes patients, with around 114 million people suffering from diabetes in the country in 2017. Similarly, in emerging countries such as Brazil and India, the prevalence of diabetes, CVDs, and HIV/AIDS is very high. In India, heart diseases accounted for 28% of all deaths in 2016, or ~2.8 million people; this is projected to reach ~4.8 million by 2020 (Source: CCDC, India).

  5. Listed below are important statistics related to major infectious diseases in developing countries: • According to the WHO, India has the highest tuberculosis burden, with an estimated incidence of 2.64 million cases in 2020. • In 2019, around 4.3 million new tuberculosis cases were reported in Southeast Asia, and 632,000 people died due to TB infections in this region (Source: WHO). • According to the National Influenza Policy 2017, around 10,000 deaths and 40,000 hospitalizations are caused due to influenza in South Africa each year. • According to the WHO, 1.2 million people in Southeast Asia suffer from malaria, with India alone accounting for ~76% of the total alaria cases. • During 2014–2016, West Africa reported the largest Ebola epidemic in the region; in two and a half years, the outbreak resulted in more than 28,600 cases and 11,325 deaths. • In 2020, an estimated 15,898 people in Brazil were at risk of Zika virus infections, down from over 30,000 cases reported a year earlier. Get Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=106829185

  6. About MarketsandMarkets™ MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve. MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

  7. Contact: Mr. Aashish Mehra MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: +1-888-600-6441 Email: sales@marketsandmarkets.com View Full Report - https://www.marketsandmarkets.com/Market-Reports/point-of-care-diagnostic- market-106829185.html

More Related